An in vitro method for preliminarily screening competing agents to enhance drug permeation in cyclodextrin inclusion complexes
10.16438/j.0513-4870.2018-1005
- VernacularTitle:提高环糊精包合物中药物渗透性的竞争剂体外筛选方法的建立
- Author:
Yi-qin RAO
1
;
Shu-xuan LI
1
;
Peng-yu LI
1
;
Yi ZHANG
1
;
Hai-yan HU
1
Author Information
1. School of Pharmacy, Sun Yat-sen University, Guangzhou 510006, China
- Publication Type:Research Article
- Keywords:
cyclodextrin;
competitive agent;
gastrointestinal tract;
permeability;
poorly soluble drug
- From:
Acta Pharmaceutica Sinica
2019;54(1):61-65
- CountryChina
- Language:Chinese
-
Abstract:
Cyclodextrin can increase the solubility of poorly soluble drugs, but also decrease the permeability of poorly soluble drugs in inclusion complexes simultaneously, which partially or completely counteracts the contribution of improvement in solubility to the oral absorption of poorly soluble drugs. If a competing agent is added to the system to compete binding sites of cyclodextrins with drugs, drug permeability can be improved by increasing the concentration of free drugs in the inclusion complex system. In this paper, a rapid in vitro screening method for competing agents of cyclodextrin inclusion complex is proposed based on the principle that good drug permeability is in accord with good cell uptake. The equilibrium constants between drugs and hydroxypropyl-beta-cyclodextrin (HPCD) were determined by phase equilibrium solubility method. Cinnarizine (CN) with a high equilibrium constant was selected as a competing agent, coumarin 6 (C6) and 9-octadecyl berberine (BD) with smaller equilibrium constants were selected as model drugs. Both changes of solubility and uptake by Caco-2 and A549 cells of C6 and BD were investigated different concentrations of CN to the HPCD solution of C6 and BD. The results showed that the uptake of C6 and BD increased in a CN concentration-dependent manner, and the solubility of C6 and BD in HPCD solution decreased with the prolongation of equilibrium time. It might be due to increased free drug concentrations that resulted from the competition of CN for drug binding sites with HPCD. In our study, in vitro cell uptake method was firstly used to validate the ability of CN as a competing agent to increase drug permeability (cell uptake). This method can be used for preliminarily screening of competing agents for drug-cyclodextrin inclusion complexes.
